Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

167 ta ish

Ish: The microbial metabolome: remodeling the therapeutic landscape in hematologic malignancies

  1. Precisely Tailoring Molecular Structure of Doxorubicin Prodrugs to Enable Stable Nanoassembly, Rapid Activation, and Potent Antitumor Effect

    Chengcheng Feng, Yuting Wang, Jinghua Xu +5

    MaqolaOchiq kirish202412 iqtibos
    ABI

  2. Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies

    Ding-Ya Sun, Yijie Hu, Xin Li +3

    Sharh maqola202412 iqtibos
    ABI

  3. Inferring Latent MicroRNA-Disease Associations on a Gene-Mediated Tripartite Heterogeneous Multiplexing Network

    Li Wen, Shulin Wang, Junlin Xu +1

    Maqola20229 iqtibos
    ABI

  4. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67

    Maqola20177 iqtibos
    ABI

  5. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy

    Lukas F. Mager, Regula Burkhard, Nicola Pett +10

    Maqola20205 iqtibos
    ABI

  6. Simultaneous quantification of mirabegron and vibegron in human plasma by HPLC-MS/MS and its application in the clinical determination in patients with tumors associated with overactive bladder

    Yutao Lou, Mengting Cheng, Qin Cao +7

    Maqola20235 iqtibos
    ABI

  7. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

    Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa +45

    Maqola20175 iqtibos
    ABI

  8. A novel microbial and hepatic biotransformation-integrated network pharmacology strategy explores the therapeutic mechanisms of bioactive herbal products in neurological diseases: the effects of Astragaloside IV on intracerebral hemorrhage as an example

    En Hu, Zhilin Li, Teng Li +9

    Maqola20235 iqtibos
    ABI

  9. Fecal 16S rRNA sequencing and multi-compartment metabolomics revealed gut microbiota and metabolites interactions in APP/PS1 mice

    Xin Cheng, Yejun Tan, Hongli Li +8

    Maqola20225 iqtibos
    ABI

  10. Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease

    Nathan D. Mathewson, Robert R. Jenq, Anna V. Mathew +18

    MaqolaOchiq kirish20164 iqtibos
    ABI

  11. A multi-omics approach to reveal critical mechanisms of activator protein 1 (AP-1)

    Fei Li, Jiaqi Tian, Lin Zhang +2

    Sharh maqola20244 iqtibos
    ABI

  12. Harnessing bacteria for tumor therapy: Current advances and challenges

    Lina Guo, Jinsong Ding, Wenhu Zhou

    Maqola20234 iqtibos
    ABI

  13. The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients

    Vyara Matson, Jessica Fessler, Riyue Bao +5

    Maqola20184 iqtibos
    ABI

  14. Dietary Fiber Confers Protection against Flu by Shaping Ly6c− Patrolling Monocyte Hematopoiesis and CD8+ T Cell Metabolism

    Aurélien Trompette, Eva S. Gollwitzer, Céline Pattaroni +7

    MaqolaOchiq kirish20183 iqtibos
    ABI

  15. Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target

    Mengwei Zhang, Jinkai Liu, Qiang Xia

    Sharh maqola20233 iqtibos
    ABI

  16. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

    Erez N. Baruch, Ilan Youngster, Guy Ben‐Betzalel +29

    Maqola20203 iqtibos
    ABI

  17. Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients

    Diwakar Davar, Amiran Dzutsev, John A. McCulloch +29

    Maqola20213 iqtibos
    ABI

  18. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation

    Ying Taur, Robert R. Jenq, Miguel‐Angel Perales +12

    Maqola20143 iqtibos
    ABI

  19. Toll-like Receptors on Hematopoietic Progenitor Cells Stimulate Innate Immune System Replenishment

    Yoshinori Nagai, Karla P. Garrett, Shoichiro Ohta +5

    Maqola20063 iqtibos
    ABI

  20. Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme

    Bret D. Wallace, Hongwei Wang, Kimberly T. Lane +8

    Maqola20103 iqtibos
    ABI

  21. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

    Romain Daillère, Marie Vétizou, Nadine Waldschmitt +33

    Maqola20163 iqtibos
    ABI

  22. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication

    Ygor Parladore Silva, Andressa Bernardi, Rudimar Luiz Frozza

    Sharh maqola20203 iqtibos
    ABI

  23. Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy

    Aadra P. Bhatt, Samuel J. Pellock, Kristen A. Biernat +16

    Maqola20203 iqtibos
    ABI

  24. The microbiota regulates hematopoietic stem cell fate decisions by controlling iron availability in bone marrow

    Dachuan Zhang, Xin Gao, Huihui Li +6

    Maqola20223 iqtibos
    ABI

  25. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

    Lisa Derosa, Bertrand Routy, Andrew Maltez Thomas +40

    Maqola20223 iqtibos
    ABI